Source: Annual Congress 2006 - Infection, trauma and emphysema
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. D. Parshin, L. M. Gudovsky, D. V. Bazarov, A. A. Volkov, E. A. Tarabrin (Moscow, Russian Federation). Modern methods of diagnostics in screening of the COPD candidates for lung volume reduction surgery. Eur Respir J 2006; 28: Suppl. 50, 1586

Member's Comments

No comment yet.

Related content which might interest you: What the radiologist can offer - the latest imaging and evaluation techniques for lung cancer screening and comorbidities Source: International Congress 2018 – Lung cancer screening and management of solitary pulmonary nodules Year: 2018 Indications for and results of surgical intervention in COPD: lung volume reduction surgery and lung transplantation Source: Annual Congress 2004 - PG4 - Management of end-stage patients with COPD Year: 2004 PG11 Modern approaches in lung cancer diagnostics and therapy Source: Paris 2018 - Educational material Year: 2018 Role of quantitative perfusion scintigraphy evaluation in determination of the efficiency of the procedure before lung volume reduction coil (LVRC) treatment for severe emphysema Source: International Congress 2016 – Airway stenting and ablation Year: 2016 Modern staging in lung cancer: from the current multidisciplinary process to novel approaches Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 Comparision of two preoperative risk assessment algorithms in lung cancer surgery. Source: International Congress 2017 – Evaluating lung function, dyspnoea and related respiratory diseases Year: 2017 Targeted vapor ablation as a new method for endoscopic lung volume reduction at segmental level Source: International Congress 2016 – Endoscopic lung volume reduction II Year: 2016 Possibility of noninvasive differential diagnostics of lung tuberculosis and lung cancer in oncologic hospital Source: Eur Respir J 2003; 22: Suppl. 45, 160s Year: 2003 Evolution in the diagnostic approach to lung cancer Source: Virtual Congress 2021 – COVID-19 and management of lung cancer Year: 2021 Non-invasive biomarkers for the evaluation of a patient at risk for lung cancer Source: Annual Congress 2013 –Early detection of lung cancer Year: 2013 Low cost biological lung volume reduction therapy for advanced emphysema Source: International Congress 2014 – Bronchoscopic treatment of emphysema: valves, coils and other Year: 2014 Novel lung function tests can improve phenotyping and differential therapy in COPD Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more Year: 2019 Biologic lung volume reduction therapy for advanced homogeneous emphysema Source: Eur Respir J 2010; 36: 20-27 Year: 2010 Lung function estimation in patients with lung cancer qualified for surgical treatment Source: Eur Respir J 2006; 28: Suppl. 50, 719s Year: 2006 Tumour tissue sampling for lung cancer management in the era of personalised therapy: what is good enough for molecular testing? Source: Eur Respir J 2014; 44: 1011-1022 Year: 2014 Indications and results of surgical intervention in COPD, including lung transplantation Source: Annual Congress 2008 - PG14 - COPD: management of advanced disease Year: 2008 PET-CT a useful staging tool for patients with non small lung cancer when applied based on surgeons‘ discretion as well as guidelines Source: Annual Congress 2010 - State of the art imaging Year: 2010 Patient selection and efficacy of valve bronchoscopic lung volume reduction (BLVR) in emphysema Source: International Congress 2016 – Airway stenting and ablation Year: 2016 Early improvements of Chartis assisted-endoscopic lung volume reduction treatments Source: Annual Congress 2012 - From the laser through the stent to the valve: the broad spectrum of interventional pneumology Year: 2012 Are FENO indices useful diagnostic tools in suspected asthma? Experience of a routine lung function laboratory Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011